Abstract
Improved microbiological techniques have led to the realization that as many as 30% of patients diagnosed with community-acquired pneumonia (CAP) are infected with atypical respiratory pathogens. Furthermore, antimicrobial resistance among isolates of Streptococcus pneumoniae, the leading cause of CAP, has skyrocketed in recent years. These 2 factors have contributed to the need for a reevaluation of optimal patient care.
Original language | English |
---|---|
Pages (from-to) | S529-S535 |
Journal | American Journal of Managed Care |
Volume | 5 |
Issue number | 9 SUPPL. |
State | Published - Jul 1999 |
Externally published | Yes |